Richard Lipton, MD: Eptinezumab Maintains Reductions in the Impact of Migraine
July 13th 2019The director of the Montefiore Headache Center and professor of neurology at Albert Einstein College of Medicine spoke about the results of an analysis of eptinezumab’s effect on the severity of migraine and its impact on patients’ lives.